Dabigatran |
|
Synonyms: N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-ß-alanine; BIBR 953; BIBR 953ZW; | |
Cat. No.: D00100 | CAS No.: 211914-51-1 |
MDL.: | Formula: C25H25N7O3 |
F.W.471.51 | Purity: 99% |
Storage: Refrigerator, Under Inert Atmosphere | |
  |

Catalog Number: | D00100 | CAS No.: | 211914-51-1 | |
MDL: | Formula: | C25H25N7O3 | ||
F.W.: | 471.51 | Purity: | 99% | |
Package: | Unit: | mg | ||
Appearance: | White to Off-White Solid | M.P.: | 268-272°C (dec.) | |
B.P.: | Density: | |||
Optical Rotation: | Refractive Index: | |||
Solubility: | Aqueous Acid | Stability: | ||
Storage: | Refrigerator, Under Inert Atmosphere | Category: | Reference Standard | |
Reference: | Hauel, N., et al.: J. Med. Chem., 45, 1757 (2002), Mungall, D., et al.: Curr. Opin. Invest. Drugs, 3, 095 (2002), Stangier, J., et al.: J. Clin. Pharmacol., 45, 555 (2005), Simon Michaelis et al,J. Med. Chem., 2012, 55 (8), pp 3934–3944 | |||
Application: | Nonpeptide, direct thrombin inhibitor. Antithrombotic. | |||
Category: | Aromatics, Heterocycles, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals |